How to Select a CDMO for Complex Molecules in 2026
Most drug developers already know how to select a CDMO, often working from a due diligence checklist for Phase I selection. The standard CDMO selection criteria cover quality history, capacity, cost, timelines, project management and regulatory support, and these still apply to complex molecules. What changes is that the usual questions stop being enough. When […]